VV
FSTX

Verity & Verity’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Verity & Verity’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,384
Closed -$289K – 97
2017
Q4 		$289K Buy
+5,384
New +$320K 0.08% 82
2017
Q3 		– Sell
-4,446
Closed -$241K – 94
2017
Q2 		$241K Hold
4,446
– – 0.07% 82
2017
Q1 		$158K Buy
4,446
+1,350
+44% +$46.3K 0.05% 86
2016
Q4 		$99K Buy
+3,096
New +$113K 0.03% 79

Other funds holding FSTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $481M AUM 46% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Verity & Verity's FSTX Position: Q1 2018 in Review

Verity & Verity sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2018, closing a stake of 5,384 shares — an estimated $289K sold.

Verity & Verity first reported a position in FSTX in Q4 2016 and held it in 4 quarters. The position peaked at $289K in Q4 2017. 39 funds tracked by Wall St. Rank hold FSTX as of Q1 2018.

  • Verity & Verity reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Verity & Verity sold 5,384 F-star Therapeutics, Inc. Common Stock shares in Q1 2018, an estimated $289K.
  • Verity & Verity first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2016 and held it in 4 quarters.
  • Verity & Verity's F-star Therapeutics, Inc. Common Stock position peaked at $289K in Q4 2017.
  • 39 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2018.

Based on Verity & Verity's 13F filing for Q1 2018, filed 25 Apr 2018.